Connor, Clark & Lunn Investment Management (CC&L)’s NextCure NXTC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-7,991
| Closed | -$264K | – | 1368 |
|
|
2022
Q3 | $264K | Buy |
7,991
+2,493
| +45% | +$82.4K | ﹤0.01% | 943 |
|
|
2022
Q2 | $310K | Buy |
5,498
+1,527
| +38% | +$86.1K | ﹤0.01% | 857 |
|
|
2022
Q1 | $232K | Sell |
3,971
-190
| -5% | -$11.1K | ﹤0.01% | 922 |
|
|
2021
Q4 | $300K | Buy |
4,161
+2,931
| +238% | +$211K | ﹤0.01% | 894 |
|
|
2021
Q3 | $99K | Buy |
+1,230
| New | +$99K | ﹤0.01% | 983 |
|